Category: Antibody Technologies
Antibody Technologies market research reports by DelveInsight
-
Anti-CD19 Antibody - Pipeline Insight, 2025
DelveInsight’s, “Anti-CD19 Antibody - Pipeline Insight, 2025” report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in Anti-CD19 Antibody pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the thera ... Read More
-
Anti-CD80 Antibody - Pipeline Insight, 2025
“Anti-CD80 Antibody - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD80 Antibody development. The report provides detailed coverage of the pipeline landscape for this mechanism ... Read More
-
Anti-CD152 Antibody - Pipeline Insight, 2025
“Anti-CD152 Antibody - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD152 Antibody development. The report provides detailed coverage of the pipeline landscape for this mechanis ... Read More
-
Anti GM-CSF Antibody - Pipeline Insight, 2025
“Anti GM-CSF Antibody - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti GM-CSF Antibody development. The report provides detailed coverage of the pipeline landscape for this mechan ... Read More
-
Anti-CD28 Antibody - Pipeline Insight, 2025
“Anti-CD28 Antibody - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD28 Antibody development. The report provides detailed coverage of the pipeline landscape for this mechanism ... Read More
-
Anti-CD274 (PD-L1) Antibody - Pipeline Insight, 2025
“Anti-CD274 (PD-L1) Antibody - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD274 (PD-L1) Antibody development. The report provides detailed coverage of the pipeline landscape f ... Read More
-
Anti-CD33 Antibody - Pipeline Insight, 2025
“Anti-CD33 Antibody - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD33 Antibody development. The report provides detailed coverage of the pipeline landscape for this mechanism ... Read More
-
Anti-CD37 Antibody - Pipeline Insight, 2025
“Anti-CD37 Antibody - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD37 Antibody development. The report provides detailed coverage of the pipeline landscape for this mechanism ... Read More
-
Anti-CD38 antibody - Pipeline Insight, 2025
DelveInsight’s, “Anti-CD38 antibody - Pipeline Insight, 2025” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Anti-CD38 antibody pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therap ... Read More
-
Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight, 2025
“Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-Mucin 1 (MUC1) Antibody development. The report provides detailed coverage of the pipeline landscape ... Read More
-
Anti-Dickkopf-1 (Dkk-1) Antibody - Pipeline Insight, 2025
“Anti-Dickkopf-1 (Dkk-1) Antibody - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-Dickkopf-1 (Dkk-1) Antibody development. The report provides detailed coverage of the pipeline l ... Read More
-
Anti-CD3 Antibody - Pipeline Insight, 2025
“Anti-CD3 Antibody - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD3 Antibody development. The report provides detailed coverage of the pipeline landscape for this mechanism of ... Read More
-
Anti-CD52 Antibody - Pipeline Insight, 2025
“Anti-CD52 Antibody - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD52 Antibody development. The report provides detailed coverage of the pipeline landscape for this mechanism ... Read More
-
Antibody Drug Conjugate - Competitive landscape, 2025
DelveInsight’s, “Antibody Drug Conjugate - Competitive landscape, 2025” report provides comprehensive insights about 180+ companies and 290+ drugs in Antibody Drug Conjugate Competitive landscape. It covers the therapeutics assessment by product type, stage, route of administration, and molecule typ ... Read More
-
Anti-CD38 antibody - Pipeline Insight, 2025
DelveInsight’s, “Anti-CD38 antibody - Pipeline Insight, 2025” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Anti-CD38 antibody pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therap ... Read More
-
Cancer Monoclonal Antibodies - Market Insights, Competitive Landscape, and Market Forecast - 2030
Cancer Monoclonal Antibodies - Market Insights, Competitive Landscape, and Market Forecast - 2030 Cancer Monoclonal Antibodies Market by Type (Humanized Antibodies, Chimeric Antibodies, Murine Antibodies), Application (Blood Cancer, Breast Cancer, Liver Cancer, Colorectal Cancer, and Others), End-Us ... Read More
-
Plasma Protein Therapeutics - Market Insights, Competitive Landscape, and Market Forecast - 2030
Plasma Protein Therapeutics - Market Insights, Competitive Landscape, and Market Forecast - 2030 Plasma Protein Therapeutics Market by Product (Immunoglobulin, Albumin, Plasma Derived Factor VIII, and Others), Application (Hemophilia, Idiopathic Thrombocytopenic, Primary Immunodeficiencies, and Othe ... Read More
-
Antibody Drug Conjugate - Market Insights, Competitive Landscape, and Market Forecast - 2030
Antibody Drug Conjugate - Market Insights, Competitive Landscape, and Market Forecast - 2030 Antibody Drug Conjugate Market By Cancer Type (Breast Cancer, Lung Cancer, Bladder Cancer, Brain Tumor, And Others), Target Type (CD19, HER2, CD22, And Others), End-User (Hospitals And Specialty Cancer Cente ... Read More
-
Biopharmaceuticals Contract Manufacturing - Market Insights, Competitive Landscape, and Market Forecast - 2030
Biopharmaceuticals Contract Manufacturing - Market Insights, Competitive Landscape, and Market Forecast - 2030 Biopharmaceuticals Contract Manufacturing Market by Product (Biologics [Monoclonal Antibodies (MABs), Proteins/Peptides, Vaccines, and Others], Biosimilar), Source (Mammalian and Non-Mammal ... Read More
-
Intravenous Immunoglobulin – Market Insight, Epidemiology, and Market Forecast – 2034
Intravenous Immunoglobulin – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Intravenous Immunoglobulin – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Intravenous Immunoglobulin, historical and forecasted epide ... Read More
-
Antibody-Mediated Graft Rejection – Market Insight, Epidemiology, and Market Forecast – 2034
Antibody-Mediated Graft Rejection – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Antibody-Mediated Graft Rejection – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Antibody-Mediated Graft Rejection, historical ... Read More
-
Anti-CD80 Antibody - Pipeline Insight, 2024
Anti-CD80 Antibody - Pipeline Insight, 2024 “Anti-CD80 Antibody - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD80 Antibody development. The report provides detailed coverage o ... Read More
-
Antibody-Mediated Graft Rejection - Pipeline Insight, 2024
Antibody-Mediated Graft Rejection - Pipeline Insight, 2024 Antibody-Mediated Graft Rejection Overview ""Antibody-Mediated Graft Rejection Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Antibody-M ... Read More
-
Anti-CD37 Antibody - Pipeline Insight, 2024
Anti-CD37 Antibody - Pipeline Insight, 2024 “Anti-CD37 Antibody - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD37 Antibody development. The report provides detailed coverage o ... Read More
-
Anti-Dickkopf-1 (Dkk-1) Antibody - Pipeline Insight, 2024
Anti-Dickkopf-1 (Dkk-1) Antibody - Pipeline Insight, 2024 “Anti-Dickkopf-1 (Dkk-1) Antibody - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-Dickkopf-1 (Dkk-1) Antibody developmen ... Read More
Research Assistance
